Krish Patel, MD

Director, Lymphoma Research; Chair, Lymphoma Research Executive Committee; SCRI

Dr. Patel joined SCRI in 2024, and, as director of lymphoma research, oversees SCRI’s comprehensive lymphoma clinical trial portfolio.

Dr. Patel joined SCRI from Swedish Cancer Institute at Swedish Medical Center in Seattle where he served as the Director of Hematologic Malignancies and Cell Therapy and held the position of Director of the Lymphoma Program. Dr. Patel received his undergraduate and Doctor of Medicine degrees from Duke University School of Medicine, followed by residency (Internal Medicine) and fellowship (Hematology/Oncology) training at his alma mater. He further honed his research expertise through a clinical research training fellowship at the National Institutes of Health.

Dr. Patel is board certified in internal medicine, medical oncology, and hematology, and actively contributes to several scientific committees and boards, including the Center for International Blood and Marrow Transplant Research, Lymphoma Research Foundation, and Southwestern Oncology Group.

In addition to his leadership role at SCRI, Dr. Patel serves as a medical oncologist at SCRI Oncology Partners in Nashville, Tenn.